Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
Stool Transplants to Treat Refractory Clostridium Difficile Colitis

It has been shown that restoration of the normal makeup of the bowel bacterial population is the most effective way to treat recurrent colitis due to Clostridium difficile. Restoration of the normal bowel bacterial population is best done by transplanting stool from a healthy donor. The investigators wish to transplant …

microbiota
clostridium difficile
  • 0 views
  • 23 Feb, 2022
  • 1 location
Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)

Hepatitis C Virus (HCV) infection is a global health problem. HCV mainly affects liver cells and causes the liver to become inflamed and damaged. This study will evaluate how safe and effective glecaprevir/pibrentasvir (GLE/PIB) is in adult and adolescent participants with acute HCV infection. GLE/PIB is an approved drug for …

  • 1 views
  • 10 Aug, 2022
  • 57 locations
Recovering Damaged Cells for Sequelae Caused by COVID-19 SARS-CoV-2

Post-acute sequelae of SARS-CoV-2 infection can cause multiple system function disorders, and complicated symptoms last for an extended period. The virus can cause this continued infection, or the virus causes immune system function disorder and post-infectious autoimmune disease. The clinical symptoms can be smell loss, taste loss to liver function …

  • 25 views
  • 02 Jun, 2021
  • 1 location
Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (PURGE-C)

The purpose of this study is to assess the efficacy of a fixed dose combination (FDC) of glecaprevir/pibrentasvir (G/P) given for 4 weeks in acute hepatitis C (HCV)-infected participants, with

pibrentasvir
ribavirin
hepatitis
glecaprevir
HIV Vaccine
  • 16 views
  • 24 Mar, 2022
  • 13 locations
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

A randomized controlled open-label clinical trial of ursodeoxycholic acid combined with total glucosides of paeony in the treatment of PBC with AIH features 1

  • 0 views
  • 02 Apr, 2021
  • 1 location
Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients

Though HAV is mainly transmitted through the fecal-oral route, infection by sexual intercourse and blood transfusion is also possible. Injection drug users (IDUs) and men who have sex with men (MSM) have a higher risk of acquiring HAV due to their behaviors. Reemerging threat of hepatitis A among MSM in …

  • 0 views
  • 25 Mar, 2021
  • 1 location
ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment (ECPforIRAE)

Preliminary data demonstrate that irAEs induced by immune checkpoint blockade can be successfully treated with ECP (Apostolova et al. NEJM 2020). Therefore this clinical phase 1/2 trial is launched to validate the finding made with the individual patient in a prospective trial. The primary objective is evaluation of safety of …

prednisolone
diarrhea
asat
infliximab
treatment regimen
  • 0 views
  • 01 Jul, 2022
  • 1 location
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings (HARAPAN II)

The purpose of this study is to conduct empiric studies of tuberculosis (TB) among prison inmates with a history of opioid dependence. This includes: a) comprehensive TB diagnostic study (symptom screening, chest x-ray, tuberculin skin test, acid-fast bacilli smear, Gene Xpert, and sputum culture) to determine best practices for screening …

naltrexone
opioid dependence
tuberculin test
isoniazid
skin test
  • 34 views
  • 06 Jun, 2022
  • 1 location
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort (IRHBRVD)

This prospective cohort study aims to provide the evidence-based clinical guide to help decide the revaccination doses of hepatitis B vaccine that the high-risk young adults without hepatitis B seroprotective antibodies (anti-HBs titer<10 mIU/mL) need to take.

engerix-b
hepatitis
Accepts healthy volunteers
  • 0 views
  • 15 Jul, 2022
  • 1 location
Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P (TARGET3D)

An open label, multicentre, international pilot study of paritaprevir/ritonavir, ombitasvir, dasabuvir with or without ribavirin or glecaprevir/pibrentasvir for people with recently acquired hepatitis C virus infection with or without HIV co-infection.

  • 17 views
  • 23 Feb, 2022
  • 11 locations